Events

Webinar – Continuous Flow Chemistry for APIs and Intermediates (Part 1 of 2)

19th April 2018

Register

Here

Cambrex will be...

Hosting a live webinar on Continuous Flow Chemistry for APIs and Intermediates

Continuous Flow Chemistry for APIs and Intermediates

Thursday April 19, 2018 – 10am New York / 3pm London

Cambrex will be hosting a live webinar on Continuous Flow Chemistry for APIs and Intermediates and we would like to invite you to join us.

Presented by:

Jonathan Knight, VP, New Product Development – Cambrex
Fredrik Stenberg, Product Manager – Cambrex

Register now

The introduction of continuous flow processing has changed the way we conduct chemistry. The oil, solvent and polymer industries have extensively used continuous flow chemistry for decades. However, when considering the fine chemical and pharmaceutical industries, continuous flow chemistry has been primarily used when batch operations are deemed unsuitable or unsafe – and in particular, where high energy chemistry is encountered.

Historically, chemists have been reluctant to embrace continuous flow development, instead preferring to develop processes with test tubes and scaling-up to large volume reactors. This method is often at odds with colleagues who have a chemical engineering background as they are more comfortable with the concept of continuous flow.

Cambrex entered continuous flow processing due to its extensive background in high energy chemistry, specifically nitrations and nitric acid oxidations and dates back to Alfred Nobel in 1896. As a result of their experience in this field, Cambrex will discuss the topic of continuous flow through two webinars.

This webinar will:

  • Provide an introduction to continuous flow processing
  • Provide a brief history of continuous flow at Cambrex
  • Discuss the obstacles to be solved and overcome when implementing continuous flow
  • Conclude with a brief look at the future of continuous flow

The second webinar in this series, will explain where pharmaceutical companies are using continuous flow equipment in synthetic development, in particular in multi-step synthesis from pre-clinical to commercial and how an integrated engineering and chemistry team can be utilized to meet these challenges.